Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-IPR-14005517Phase 4Recruiting
Phase 4 trial of dexmedetomidine in carotid atheroma (CAS) (2 arms), sponsored by Subei People's Hospital. Primary endpoints: Mini-Mental State Examination score, Brain-derived neurotrophic factor and 3 more. Started Nov 2014; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-IPR-14005517.